Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT07215936
PHASE2
Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen
Sponsor: Sohag University
View on ClinicalTrials.gov
Summary
Dose\_dense Capecitabine Schedule in colorectal cancers
Official title: Dose_dense Capecitabine Schedule [7days on _7days Off] in Colorectal Cancer in Comparison With Standered Regimen
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-09-25
Completion Date
2028-09
Last Updated
2025-10-14
Healthy Volunteers
No
Conditions
Interventions
DRUG
Arm A:Dose_dense Capecitabine in Colorectal cancer
Appling dose \_dense Capecitabine 1750mg/m2 for one week then one week off Cycle repeated every 2 weeks
DRUG
Arm B : standard dose Capecitabine
Pateints will receive capecitabine 1000 mg/m2 for 2 weeks then one week off
Locations (1)
Sohag university hospital
Sohag, Egypt